Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK
Woman and Man Max 99 years
MedImmune, Ltd, a wholly owned subsidiary of AstraZeneca UK
Update Il y a 4 ans
A Phase 2B study of multiple doses to evaluate the safety and treatment benefits of MEDI2070 in subjects with Crohn's Disease who have failed or are Intolerant to Anti Tumor Necrosis Factor-Alpha Therapy
The primary objective of this study is to evaluate the efficacy of MEDI2070 versus placebo to induce clinical remission based on the CDAI score at Week 8 in subjects with moderate to severe CD who hav...
Country
None
organs
None
Specialty
None
unknown
More information